RESEARCH · MOTS-C
What is MOTS-c? A Research Overview of the Mitochondrial-Derived Peptide
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a short peptide encoded not in the cell nucleus but in mitochondrial DNA. Since it was first described in 2015 it has become one of the most studied mitochondrial-derived peptides in metabolism and ageing research. This article summarises what the published studies report, where the evidence is still thin, and general handling background for laboratories. PurixLab’s MOTS-C 10mg is a lyophilized research vial supplied for laboratory research use only.
Where MOTS-c comes from
Mitochondria carry their own small genome. The earlier discovery of humanin, a signalling peptide encoded by a short open reading frame (sORF) in mitochondrial DNA, suggested that other such sORFs might exist. In 2015 Lee and colleagues reported an sORF inside the mitochondrial 12S rRNA gene that encodes a 16-amino-acid peptide, which they named MOTS-c [1].
A 2020 review counted eight mitochondrial-derived peptides (MDPs) identified to date. MOTS-c is the only one encoded in the 12S rRNA gene (MT-RNR1); humanin and the six small humanin-like peptides (SHLP1–6) are encoded in the 16S rRNA gene [2]. The same review describes MDPs as part of a retrograde signalling network that communicates mitochondrial status to the rest of the cell and to distant tissues [2].
Key findings in cell and animal models
Metabolic signalling and AMPK
In the original report, skeletal muscle appeared to be the primary target organ. In cells, MOTS-c inhibited the folate cycle and the de novo purine biosynthesis tethered to it, which led to activation of AMPK, a central cellular energy sensor. In mice, MOTS-c treatment prevented age-dependent and high-fat-diet-induced insulin resistance as well as diet-induced obesity [1].
Movement to the nucleus
A 2018 study found that under metabolic stress such as glucose restriction, MOTS-c translocated to the nucleus in an AMPK-dependent manner. There it regulated a broad range of genes, including genes with antioxidant response elements (AREs), and interacted with stress-responsive transcription factors such as NRF2 [3]. The authors interpret this as evidence that the mitochondrial genome can actively influence nuclear gene expression.
Physical capacity in ageing mice
Reynolds and colleagues reported that MOTS-c enhanced physical performance in young (2-month), middle-aged (12-month) and old (22-month) mice, and that intermittent treatment started late in life (23.5 months) increased physical capacity and healthspan in mice. At the molecular level it regulated nuclear genes related to metabolism and proteostasis, skeletal-muscle metabolism, and myoblast adaptation to metabolic stress [4].
Adipose tissue
In ovariectomised mice, a model of oestrogen loss, MOTS-c treatment prevented ovariectomy-induced obesity and insulin resistance, increased brown-fat activation and reduced fat accumulation and inflammatory infiltration in white adipose tissue. An AMPK pathway blocker attenuated its effects on adipocyte lipid metabolism [5].
What human observational and genetic studies show
Human data on MOTS-c are so far mostly observational: they measure naturally occurring (endogenous) MOTS-c rather than testing it as an intervention.
- Exercise. In humans, exercise induced endogenous MOTS-c expression in skeletal muscle and in circulation [4].
- Ageing muscle. In healthy men, circulating MOTS-c was lower with age, yet middle-aged (45–55 y) and older (70–81 y) men had about 1.5-fold higher skeletal-muscle MOTS-c expression than young men. Muscle expression was associated with markers of slow-type fibres and, unlike earlier cell-culture work, was not associated with ARE-related genes [6].
- Type 2 diabetes. In a cross-sectional study of 225 people, serum MOTS-c was significantly lower in type 2 diabetes than in controls and correlated negatively with age, HbA1c and glucose [7].
- Mixed results across populations. A 2024 meta-analysis of seven studies (602 participants) found lower circulating MOTS-c in diabetes but higher levels in an obesity subgroup, underlining that the direction of association differs by population [8].
- A natural variant. The Asian-specific mitochondrial variant m.1382A>C changes lysine-14 of MOTS-c to glutamine (K14Q). In a meta-analysis of three cohorts (n = 27,527), men but not women carrying the C allele had a higher prevalence of type 2 diabetes. In high-fat-fed male mice, native MOTS-c reduced weight and improved glucose tolerance, whereas the K14Q form did not [9]. An earlier letter had proposed, as a hypothesis, that the same variant might relate to longevity in Japanese people [10].
All of these are associations. They do not show that MOTS-c causes the outcomes measured, and none of them tests MOTS-c as a product in people.
What remains unknown
- Human interventional evidence is scarce. A 2026 sports-medicine review that covered MOTS-c among other unapproved peptides concluded that, while these compounds show effects in animal models, rigorous human safety data are scarce [11].
- Mechanism outside the dish. The folate–AMPK and nuclear-translocation mechanisms come mainly from cell lines and rodents [1,3]. In human muscle, MOTS-c expression did not track the ARE-related genes seen in culture [6].
- Measurement. Circulating levels vary across studies and populations, and the meta-analysis found substantial subgroup differences [8].
- Who did the research. Several foundational papers disclose that some authors were consultants for and shareholders of CohBar, Inc. [3,4,9]. Independent replication remains valuable.
General laboratory storage background
Laboratories should always follow the product label, any batch documentation and their own approved procedures. As general background, peptide suppliers’ technical guides describe broadly similar practice for lyophilized (freeze-dried) peptides:
- Keep it dry, dark and cold. Lyophilized peptides should be stored away from heat, light and moisture; for longer-term storage, guides commonly recommend about −20 °C [12,13].
- Oxidation-prone residues. GenScript notes that peptides containing Cys, Met or Trp are prone to oxidation and benefit from limited air exposure [12]. The published MOTS-c sequence contains both methionine and tryptophan [1].
- Avoid condensation. Let a cold vial reach room temperature, ideally in a desiccator, before opening [13].
- Limit freeze–thaw cycles. Aliquoting by planned experiment reduces freeze–thaw cycles and air exposure [12].
- Solutions are short-lived. Peptides in solution have a much shorter shelf life than the dry powder [12,13].
This is general laboratory information, not a protocol, and it contains no instructions for human use.
MOTS-C 10mg at PurixLab
MOTS-C 10mg: a labelled lyophilized research vial with 10mg per vial, C$54 per vial (CAD, before tax), supplied for laboratory research only. Batch documentation is available on request.
PurixLab ships within Canada only, from stock held in Toronto. Standard shipping is C$15, and shipping is free when the product subtotal is C$200 or more after discounts. Orders outside the GTA ship by Canada Post Xpresspost. Prices are in CAD and taxes are calculated from your shipping address at checkout.
In Toronto and the GTA, our own team delivers orders the same day or the next day. There is no fixed GTA delivery fee: after you place your order, we email you to confirm the delivery time and any delivery charge, and then you pay. There is no storefront or local pickup.
Payment is by Interac e-Transfer (instructions are shown at checkout) or by cryptocurrency through Plisio (Bitcoin, Ethereum, USDT and more): choose Plisio at checkout and you are sent to a secure Plisio payment page after placing the order. Codes: WELCOME10 takes 10% off eligible orders below C$400; PURIX20 takes 20% off eligible orders of C$400 or more before discount and tax. One offer per order; offers do not stack.
For laboratory research use only. Not for human or veterinary use, not for consumption, injection or application to skin, and purchasers must be 18 or older. The studies summarised above describe specific materials in published research; they are not claims about any PurixLab product.
Questions or batch documentation requests: [email protected] · Shipping & Delivery · Toronto & GTA delivery · PurixLab FAQ
References
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-54. PubMed 25738459 · PMC4350682 · doi:10.1016/j.cmet.2015.02.009
- Merry TL, Chan A, Woodhead JST, et al. Mitochondrial-derived peptides in energy metabolism. Am J Physiol Endocrinol Metab. 2020;319(4):E659-E666. PubMed 32776825 · PMC7750512 · doi:10.1152/ajpendo.00249.2020
- Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metab. 2018;28(3):516-524.e7. PubMed 29983246 · PMC6185997 · doi:10.1016/j.cmet.2018.06.008
- Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. PubMed 33473109 · PMC7817689 · doi:10.1038/s41467-020-20790-0
- Lu H, Wei M, Zhai Y, et al. MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction. J Mol Med (Berl). 2019;97(4):473-485. PubMed 30725119 · doi:10.1007/s00109-018-01738-w
- D'Souza RF, Woodhead JST, Hedges CP, et al. Increased expression of the mitochondrial derived peptide, MOTS-c, in skeletal muscle of healthy aging men is associated with myofiber composition. Aging (Albany NY). 2020;12(6):5244-5258. PubMed 32182209 · PMC7138593 · doi:10.18632/aging.102944
- Ramanjaneya M, Bettahi I, Jerobin J, et al. Mitochondrial-Derived Peptides Are Down Regulated in Diabetes Subjects. Front Endocrinol (Lausanne). 2019;10:331. PubMed 31214116 · PMC6554664 · doi:10.3389/fendo.2019.00331
- Zhou Q, Yin S, Lei X, et al. The correlation between mitochondrial derived peptide (MDP) and metabolic states: a systematic review and meta-analysis. Diabetol Metab Syndr. 2024;16(1):200. PubMed 39160573 · PMC11331736 · doi:10.1186/s13098-024-01405-w
- Zempo H, Kim SJ, Fuku N, et al. A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c. Aging (Albany NY). 2021;13(2):1692-1717. PubMed 33468709 · PMC7880332 · doi:10.18632/aging.202529
- Fuku N, Pareja-Galeano H, Zempo H, et al. The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity? Aging Cell. 2015;14(6):921-3. PubMed 26289118 · PMC4693465 · doi:10.1111/acel.12389
- Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026;56(8):1921-1935. PubMed 41966639 · doi:10.1007/s40279-026-02437-0
- GenScript. Peptide Storage and Handling Guidelines (technical resource). GenScript
- AAPPTec. Handling and Storage of Peptides — FAQ (technical resource). AAPPTec